Walleye Trading LLC Glaukos Corp Put Options Transaction History

Walleye Trading LLC

8 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q1 2024 May 15, 2024	BUY	$76.4 - $96.33 $213,920 - $269,724	2,800 New	2,800 $264,000
Q3 2023 Nov 14, 2023	BUY	$69.23 - $79.09 $263,074 - $300,542	3,800 New	3,800 $285,000
Q3 2022 Nov 14, 2022	BUY	$46.84 - $58.49 $65,576 - $81,886	1,400 New	1,400 $75,000
Q4 2021 Feb 14, 2022	SELL	$40.27 - $56.99 $104,702 - $148,174	-2,600 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$47.43 - $84.23 $47,430 - $84,230	1,000 Added 62.5%	2,600 $125,000
Q2 2021 Aug 16, 2021	SELL	$73.06 - $97.7 $51,142 - $68,390	-700 Reduced 30.43%	1,600 $136,000
Q1 2021 May 17, 2021	SELL	$70.43 - $97.42 $77,473 - $107,162	-1,100 Reduced 32.35%	2,300 $193,000
Q4 2020 Feb 16, 2021	BUY	$48.9 - $75.26 $166,260 - $255,884	3,400 New	3,400 $256,000

345

46.6M

132K

188K

Ticker GKOS
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 47,596,900
Market Cap $7.44B
Description
Glaukos Corporation, an ophthalmic medical technology and pharmaceutical company, focuses on the development of novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It offers iStent, iStent inject, iStent inject W micro-bypass stents that enhance aqueous humor outflow inserted in cataract surgery to treat mild-...

Get notified when there are updates to the investment portfolio of Walleye Trading LLC, based on Form 13F filings with the SEC.

Stay updated on Walleye Trading LLC with notifications on news.